| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.19B | 14.72B | 13.82B | 13.63B | 14.33B | 12.84B |
| Gross Profit | 12.09B | 11.65B | 10.75B | 10.69B | 11.16B | 10.17B |
| EBITDA | 6.72B | 6.41B | 5.80B | 5.86B | 6.51B | 5.41B |
| Net Income | 4.37B | 4.19B | 3.82B | 3.81B | 4.22B | 3.53B |
Balance Sheet | ||||||
| Total Assets | 32.79B | 33.04B | 29.76B | 26.74B | 24.59B | 21.16B |
| Cash, Cash Equivalents and Short-Term Investments | 19.58B | 21.17B | 19.83B | 18.05B | 17.03B | 13.60B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.84B | 5.94B | 5.36B | 5.06B | 5.63B | 5.45B |
| Stockholders Equity | 26.95B | 27.10B | 24.41B | 21.68B | 18.96B | 15.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.90B | 4.58B | 2.85B | 4.46B | 3.97B |
| Operating Cash Flow | 0.00 | 5.65B | 4.86B | 2.98B | 4.65B | 4.22B |
| Investing Cash Flow | 0.00 | -2.97B | -1.84B | -714.00M | -188.00M | -237.00M |
| Financing Cash Flow | 0.00 | -1.34B | -1.24B | -1.24B | -1.03B | -929.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥65.95B | 12.38 | 13.96% | 2.16% | 10.89% | -4.99% | |
77 Outperform | ¥74.98B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
74 Outperform | ¥63.63B | 13.29 | ― | 2.41% | 13.05% | 4.42% | |
72 Outperform | ¥51.41B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
70 Outperform | ¥96.25B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
68 Neutral | ¥32.90B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |